Literature DB >> 30029051

Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia?

M Strassnig1, C Bowie2, A E Pinkham3, D Penn4, Elizabeth W Twamley5, Thomas L Patterson5, P D Harvey6.   

Abstract

BACKGROUND: Negative symptoms and cognitive impairments predict difficulties in aspects of everyday functioning in schizophrenia, with little research to date attempting to determine if there are threshold levels of impairment required to predict the severity of functional deficits.
METHODS: People diagnosed with chronic schizophrenia (n = 821) were assessed with the MCCB and PANSS, and rated by high contact informants with SLOF. Negative symptoms of reduced emotional experience were specifically targeted for analysis because of their previously identified relationships with social outcomes. We identified patients with moderate negative symptoms (at least one PANSS item ≥4) versus less severe symptoms (PANSS items ≤3) and divided patients on the basis of a single latent-trait global cognition score (neuropsychologically normal vs neuropsychologically impaired; performance at or below 1.0 SD from the normative population mean, T = 40), then examined correlations between cognition, negative symptoms and everyday functioning in the groups with lower and higher negative symptoms and those with/without cognitive impairment.
RESULTS: Even low levels of negative symptoms were correlated with ratings of social functioning. Cognitive performance in the neuropsychologically normal range, in contrast, was not correlated with any aspects of everyday functioning while more impaired performance predicted greater functional impairments.
CONCLUSIONS: Even minimal symptoms may be a target for clinical attention in the domains of negative symptoms, consistent with previous findings regarding social deficits in populations with modest negative symptoms (e.g., schizotypal personality disorder). Cognitive rehabilitation treatments might not improve social functioning if even low levels of negative symptoms (social amotivation) are present.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30029051     DOI: 10.1016/j.jpsychires.2018.06.018

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  19 in total

1.  Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning.

Authors:  Philip D Harvey; Elizabeth Deckler; Mackenzie T Jones; L Fredrik Jarskog; David L Penn; Amy E Pinkham
Journal:  J Psychiatr Res       Date:  2019-05-10       Impact factor: 4.791

2.  Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review.

Authors:  Zi Ying Wee; Samantha Wei Lee Yong; Qian Hui Chew; Cuntai Guan; Tih Shih Lee; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2019-03-19       Impact factor: 3.575

3.  Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes.

Authors:  Philip D Harvey; Anzalee Khan; Alexandra Atkins; Richard Se Keefe
Journal:  Psychiatry Res       Date:  2019-01-15       Impact factor: 3.222

4.  Predictors of social functioning in patients with higher and lower levels of reduced emotional experience: Social cognition, social competence, and symptom severity.

Authors:  Philip D Harvey; Elizabeth Deckler; Fredrik Jarskog; David L Penn; Amy E Pinkham
Journal:  Schizophr Res       Date:  2018-11-13       Impact factor: 4.939

5.  Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments.

Authors:  Philip D Harvey; Michelle L Miller; Raeanne C Moore; Colin A Depp; Emma M Parrish; Amy E Pinkham
Journal:  Innov Clin Neurosci       Date:  2021-01-01

6.  The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia.

Authors:  Xiaoyan He; Qingyan Ma; Yajuan Fan; Binbin Zhao; Wei Wang; Feng Zhu; Xiancang Ma; Lina Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

7.  Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.

Authors:  Martin T Strassnig; Michelle L Miller; Raeanne Moore; Colin A Depp; Amy E Pinkham; Philip D Harvey
Journal:  Psychiatry Res       Date:  2021-04-04       Impact factor: 11.225

8.  Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague-Dawley Rats.

Authors:  Marta Anna Lech; Monika Leśkiewicz; Kinga Kamińska; Zofia Rogóż; Elżbieta Lorenc-Koci
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

9.  Daily Ecological Momentary Assessments of happy and sad moods in people with schizophrenia and bipolar disorders: What do participants who are never sad think about their activities and abilities?

Authors:  Sara E Jones; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2021-06-16

10.  Using a Meta-cognitive Wisconsin Card Sorting Test to measure introspective accuracy and biases in schizophrenia and bipolar disorder.

Authors:  Bianca A Tercero; Michelle M Perez; Noreen Mohsin; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  J Psychiatr Res       Date:  2021-06-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.